Approval · Notice of Compliance 7271 · 2005
MERREM: Notice of Compliance 7271
Issued July 28, 2005
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7271
- Date
- July 28, 2005
- Company
- Astrazeneca Canada IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New indication: use as single agent therapy for treatment of complicated skin and skin structure infections
- Therapeutic class
- Antibiotic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MERREM | Not yet assigned | — |
Medicinal ingredients
- MEROPENEM 500 MG per VIAL